Regardless of the sequential decrease in Current Liabilities, during the fourth quarter 2022, Quick Ratio deteriorated to 0.45 a new company low.

Within Medical Laboratories industry 37 other companies have achieved higher Quick Ratio than Genetron Holdings Ltd in fourth quarter 2022. While Quick Ratio total ranking in the fourth quarter 2022 has deteriorated compared to the prior quarter from 3041 to 3166.

Explain Quick Ratio?
How much Cash & cash equivalents GTH�s has?
What are GTH�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

GTH Quick Ratio	(Dec 31 2022) Q4	0 Q3	0 Q2	0 Q1	(Dec 31 2021) Q4
Y / Y Current Liabilities Change	35.88 %	35.88 %	35.88 %	35.88 %	18.61 %
Y / Y Cash & cash equivalent Change	-72.42 %	-74.52 %	-74.52 %	-74.52 %	-57.08 %
Quick Ratio MRQ	0.45	0.45	0.45	0.45	2.23
GTH's Total Ranking	# 3166	# 3041	# 3073	# 3166	# 1374
Seq. Current Liabilities Change	0 %	0 %	0 %	35.88 %	0 %
Seq. Cash & cash equivalent Change	0 %	0 %	0 %	-72.42 %	-7.61 %

Quick Ratio fourth quarter 2022 Company Ranking
Within:	No.
Medical Laboratories Industry	# 38
Healthcare Sector	# 999
Overall Market	# 3166

Quick Ratio Statistics
High	Average	Low
6.01	2.96	0.45
(Dec 31 2020)		(Dec 31 2022)

Financial Statements
Genetron Holdings Ltd's Current Liabilities	$ 57 Millions	Visit GTH's Balance sheet
Genetron Holdings Ltd's Cash & cash equivalent	$ 26 Millions	Visit GTH's Balance sheet
Source of GTH's Sales		Visit GTH's Sales by Geography

Cumulative Genetron Holdings Ltd's Quick Ratio

GTH's Quick Ratio for the trailling 12 Months

GTH Quick Ratio	(Dec 31 2022) 12 Months	0 12 Months	0 12 Months	0 12 Months	(Dec 31 2021) 12 Months
Y / Y Current Liabilities TTM Growth	35.88 %	32.09 %	27.98 %	23.5 %	18.61 %
Y / Y Cash & cash equivalent TTM Growth	-74.02 %	-67.23 %	-61.1 %	-56.8 %	-53.62 %
Quick Ratio TTM	0.45	0.8	1.24	1.76	2.36
Total Ranking TTM	# 4837	# 4345	# 4172	# 4428	# 1485
Seq. Current Liabilities TTM Growth	7.07 %	7.61 %	8.23 %	8.97 %	4.08 %
Seq. Cash & cash equivalent TTM Growth	-39.63 %	-30.62 %	-23.44 %	-18.99 %	-23.85 %

Quick ratio ranking by company, industry and sector >> Back to GTH Financial Strength Comparisons >> Go to Compare GTH Quick Ratio to its Competitors

On the trailing twelve months basis Due to unchanged in Current Liabilities in the Q4 2022 to $56.53 millions, cumulative Quick Ratio decreased to 0.45 below the Genetron Holdings Ltd average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Laboratories industry 51 other companies have achieved higher Quick Ratio than Genetron Holdings Ltd. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2022 from 4345 to 4837.

Explain Quick Ratio?
How much Cash & cash equivalents GTH�s has?
What are GTH�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Laboratories Industry	# 52
Healthcare Sector	# 1206
Within the Market	# 4837

trailing twelve months Quick Ratio Statistics
High	Average	Low
6.01	2.71	0.45
(Dec 31 2020)		(Dec 31 2022)

Companies with similar Quick Ratio in the quarter ending Dec 31 2022, within Medical Laboratories Industry	Quick Ratio	Dec 31 2022 MRQ Cash & cash equivalent	Dec 31 2022 MRQ Current Liabilities
Bionexus Gene Lab Corp	1.07	$ 2.119 Millions	$ 1.988 Millions
Psychemedics Corporation	1.01	$ 4.750 Millions	$ 4.681 Millions
Fulgent Genetics Inc	0.90	$ 79.506 Millions	$ 88.107 Millions
Centogene N v	0.90	$ 40.265 Millions	$ 44.857 Millions
Foxo Technologies Inc	0.80	$ 5.515 Millions	$ 6.913 Millions
Nrc Health	0.72	$ 25.026 Millions	$ 34.974 Millions
Capforce Inc	0.70	$ 7.440 Millions	$ 10.592 Millions
Genetron Holdings Ltd	0.45	$ 25.556 Millions	$ 56.525 Millions
LUDWIG ENTERPRISES, INC.	0.38	$ 0.516 Millions	$ 1.342 Millions
Radnet Inc	0.38	$ 181.006 Millions	$ 470.867 Millions
Ge Healthcare Technologies Inc	0.36	$ 1,440.000 Millions	$ 3,977.000 Millions
Iqvia Holdings Inc	0.35	$ 1,309.000 Millions	$ 3,742.000 Millions
Akumin Inc	0.31	$ 59.424 Millions	$ 193.884 Millions
Evolutionary Genomics Inc	0.29	$ 0.577 Millions	$ 2.013 Millions
Fortrea Holdings Inc	0.28	$ 112.000 Millions	$ 405.600 Millions
Charles River Laboratories International inc	0.28	$ 233.912 Millions	$ 850.568 Millions
Fresh2 Group Ltd	0.23	$ 0.610 Millions	$ 2.602 Millions
Quest Diagnostics Inc	0.20	$ 315.000 Millions	$ 1,566.000 Millions
Luna Innovations Inc	0.19	$ 6.024 Millions	$ 31.091 Millions
Koninklijke Philips Nv	0.18	$ 1,561.280 Millions	$ 8,917.606 Millions
Inotiv Inc	0.15	$ 20.820 Millions	$ 136.127 Millions
Labcorp Holdings Inc	0.13	$ 320.600 Millions	$ 2,480.100 Millions
Icon Plc	0.10	$ 290.481 Millions	$ 2,885.521 Millions

Date modified: 2026-06-22T16:58:57+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.